Researchers Examine Access To GeneXpert TB Test In High-Burden Countries

Center for Global Health Policy’s “Science Speaks”: Survey shows Xpert TB diagnosis costly, out of reach in countries where private care predominates
Rabita Aziz, policy research coordinator for the Center for Global Health Policy, highlights a correspondence published in The Lancet Global Health’s February issue discussing access to the GeneXpert MTB/RIF diagnostic test for drug-resistant tuberculosis in high-burden countries…” (1/27).